Côte d'Ivoire vs Korea: Proportion of isolates with resistance to azithromycin reported to
Côte d'Ivoire
0
in 2018
Korea
0.8696
in 2018
Côte d'Ivoire rank
41st
Korea rank
38th
Proportion of isolates with resistance to azithromycin reported to over time
- Côte d'Ivoire
- Korea
How they compare
Korea currently reports 0.8696 against 0 in Côte d'Ivoire, a difference of 0.8696.
The two have swapped places 1 time across 6 shared years of data; in 2013 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 41st and Korea ranks 38th of 47 countries.
Côte d'Ivoire has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, Côte d'Ivoire or Korea?
- Korea, at 0.8696 against 0 in Côte d'Ivoire as of 2018.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between Côte d'Ivoire and Korea?
- 0.8696, with Korea ahead.
- How many years of comparable data are there for Côte d'Ivoire and Korea?
- 6 years are reported by both, from 2013 to 2018.
- How do Côte d'Ivoire and Korea rank globally for proportion of isolates with resistance to azithromycin reported to?
- Côte d'Ivoire ranks 41st and Korea ranks 38th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.